A comparison of FDA and EMA drug approval: implications for drug development and cost of care.
about
A comparison of FDA and EMA drug approval: implications for drug development and cost of care.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A comparison of FDA and EMA dr ...... development and cost of care.
@en
A comparison of FDA and EMA dr ...... development and cost of care.
@nl
type
label
A comparison of FDA and EMA dr ...... development and cost of care.
@en
A comparison of FDA and EMA dr ...... development and cost of care.
@nl
prefLabel
A comparison of FDA and EMA dr ...... development and cost of care.
@en
A comparison of FDA and EMA dr ...... development and cost of care.
@nl
P1433
P1476
A comparison of FDA and EMA dr ...... development and cost of care.
@en
P2093
Bradford R Hirsch
Lynn J Howie
P304
1195, 1198-1200, 1202 passim
P577
2013-12-01T00:00:00Z